Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D)

Primary Care Diabetes

Volumn 4, Issue 4, 2010, Pages 231-239

  Saaristo, Timo ^a,b   Moilanen, Leena ^c   Jokelainen, Jari ^d   Korpi Hyövälti, Eeva ^e   Vanhala, Mauno ^c   Saltevo, Juha ^f   Niskanen, Leo ^c   Peltonen, Markku ^g   Oksa, Heikki ^a   Cederberg, Henna ^d   Tuomilehto, Jaakko ^h   Uusitupa, Matti ⁱ   Keinänen Kiukaanniemi, Sirkka ^d,j  

^a PIRKANMAA HOSPITAL DISTRICT   (Finland)

^b Finnish Diabetes Association   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^f Central Finland Hospital District   (Finland)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ UNIVERSITY OF EASTERN FINLAND   (Finland)

^j North Ostrobothnia Hospital District   (Finland)

more..

Author keywords

Cardiovascular disease; FINDRISC; Framingham risk engine; High risk strategy; Impaired fasting glucose; Impaired glucose tolerance; Metabolic syndrome; Primary health care; SCORE; Screening; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; FEMALE; FINLAND; FINNISH DIABETES RISK SCORE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SCORING SYSTEM; SCREENING; SYSTEMATIC CORONARY RISK EVALUATION FORMULA;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FINLAND; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTORS;

EID: 78649921829     PISSN: 17519918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcd.2010.05.005     Document Type: Article

References (42)

1. X. Pan, G. Li, and Y. Hu Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study Diab. Care 20 1997 537 544
2. J. Tuomilehto, J. Lindström, and J. Eriksson Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N. Engl. J. Med. 344 2001 1343 1350 (Pubitemid 32378388)
3. The Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N. Engl. J. Med. 346 2002 393 403
4. K. Kosaka, M. Noda, and T. Kuzuya Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males Diab. Res. Clin. Pract. 67 2005 152 162
5. A. Ramachandran, C. Snehalatha, and S. Mary The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Diabetologia 49 2006 289 297
6. J. Crandall, W. Knowler, and S. Kahn The prevention of type 2 diabetes Nat. Clin. Pract./Endocrinol. Metab. 4 2008 382 393
7. R. Ackerman, E. Finch, and E. Brizendine Translating the Diabetes Prevention Program into the community. The DEPLOY pilot study Am. J. Prev. Med. 35 2008 357 363
8. R. Ackermann, and D. Marrero Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community. The YMCA model Diabetes Educ. 33 2007 69 78
9. P. Absetz, R. Valve, and B. Oldenburg Type 2 diabetes prevention in the "real world": one-year results of the GOAL Implementation Trial Diab. Care 30 2007 2465 2470
10. P. Absetz, B. Oldenburg, and N. Hankonen Type 2 diabetes prevention in the real world. Three-year results of the GOAL Lifestyle Implementation Trial Diab. Care 32 2009 1418 1420
11. P. Schwarz, J. Schwarz, and A. Schuppenies Development of a diabetes prevention management program for clinical practice Public Health Rep. 122 2007 258 263
12. K. Makrilakis, S. Liatis, S. Grammatikou, D. Perrea, and N. Katsilambros Implementation and effectiveness of the first community lifestyle intervention programme to prevent type 2 diabetes in Greece. The DE-PLAN study Diabet. Med. 27 2010 459 465
13. P. Schwarz, P. Reddy, C. Greaves, J. Dunbar, and J. Schwarz Diabetes Prevention in Practice. Dresden WCPD 2010 2010 TUMAINI Institute for Prevention Management Dresden
14. Finnish Diabetes Association, Programme for the Prevention of Type 2 Diabetes in Finland 2003-2010, Jyväskylä, Finnish Diabetes Association, Gummerus Printing, 2003 (www.diabetes.fi/english ), pp. 1-94.
15. Finnish Diabetes Association, Implementation of Type 2 Diabetes Prevention Plan, Project Plan 2003-2007, FIN-D2D Project, Tampere, Finnish Diabetes Association, Kirjapaino Hermes Oy, 2006 (www.diabetes.fi/english ), pp. 1-88.
16. T. Saaristo, M. Peltonen, S. Keinänen-Kiukaanniemi for the FIN-D2D Study Group National type 2 diabetes prevention programme in Finland: FIN-D2D Int. J. Circum. Health 66 2007 101 112
17. National Public Health Institute, SOTKAnet Indicator Bank, Helsinki, National Public Health Institute, 2005-2009 (http://uusi.sotkanet.fi/portal/ page/portal/etusivu ).
18. J. Lindström, and J. Tuomilehto The diabetes risk score: a practical tool to predict type 2 diabetes risk Diab. Care 26 2003 725 731
19. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus, Geneva, World Health Organization, Report No. 99.2, 1999, 1-59.
20. S. Grundy, J. Cleeman, and S. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart. Lung, and Blood Institute Scientific Statement: executive summary Circulation 112 2005 e285 e290
21. P. Zimmet, D. Magliano, and Y. Matsuzawa The metabolic syndrome: a global public health problem and a new definition J. Atheroscler. Thromb. 12 2005 295 300
22. K. Anderson, P. Wilson, P. Odell, and W. Kannel An updated coronary risk profile. A statement for health professionals Circulation 83 1991 356 362
23. R. Conroy, K. Pyörälä, A. Fitzgerald on behalf of the SCORE project group Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur. Heart J. 24 2003 987 1003
24. J. Schwarz, S. Bornstein, J. Schulze, and P. Schwarz Implementation of the Saxon Diabetes Prevention Program in Germany. Diabetes Prevention in Practice. Dresden WCPD 2010 2010 TUMAINI Institute for Prevention Management Dresden
25. S. Marchl, C. Neuhold, K. Reis-Klingspiegl, and U. Püringer Community Based Diabetes Prevention in Austria. Diabetes Prevention in Practice. Dresden WCPD 2010 2010 TUMAINI Institute for Prevention Management Dresden
26. T. Saaristo, M. Peltonen, and J. Lindström Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome Diab. Vasc. Dis. Res. 2 2005 67 72
27. The DECODE Study Group Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts Diab. Care 26 2003 61 69
28. M. Bartnik, L. Rydén, and K. Malmberg Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart Heart 93 2007 72 77
29. W. Rathmann, B. Haastert, and A. Icks High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000 Diabetologia 46 2003 182 189
30. E. Gregg, B. Cadwell, and Y. Cheng Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S Diab. Care 27 2004 2806 2812
31. K. Kotseva, D. Wood, and G. De Backer EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries Eur. J. Cardiovasc. Prev. Rehabil. 16 2009 121 137
32. T. Saaristo, N. Barengo, and E. Korpi-Hyövälti High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population BMC Public Health 8 2008 423 10.1186/1471-2458-8-423
33. K. Silventoinen, J. Pankow, and J. Lindström The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality Eur. J. Cardiovasc. Prev. Rehabil. 12 2005 451 458
34. T. Laatikainen, H. Tapanainen, G. Alftan, et al., The National FINRISK 2002 Study. Statistics, Helsinki, National Public Health Institute B7/2003 (in Finnish), 2003, http://www.ktl.fi/publications/2003/b72.pdf.
35. M. Peltonen, K. Harald, S. Männistö, et al., The National FINRISK 2007 Study. Statistics, Helsinki, National Public Health Institute B35/2008 (in Finnish), 2008 (http://www.ktl.fi/attachments/suomi/julkaisut/ julkaisusarja-b/2008/2008b35.pdf ), pp. 1-710.
36. J. Echouffo-Tcheuqui, L. Sargeant, and A. Prevost How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes? Diabet. Med. 25 2008 1433 1439
37. M. Uusitupa, M. Peltonen, and J. Lindström Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study - secondary analysis of the randomized trial PLoS ONE 4 5 2009 e5656 10.1371/journal.pone. 0005656
38. U. Bulugahapitiya, S. Siyambalapitiya, J. Sithole, and I. Idris Is diabetes a coronary risk equivalent? Systematic review and meta-analysis Diabet. Med. 26 2009 142 148
39. G. Hu, P. Jousilahti, Q. Qiao, S. Katoh, and J. Tuomilehto Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction Diabetologia 48 2005 856 861
40. G. Hu, P. Jousilahti, Q. Qiao, M. Peltonen, S. Katoh, and J. Tuomilehto The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease J. Am. Coll. Cardiol. 45 2005 1413 1418
41. H.C. Gerstein Glucose: a continuous risk factor for cardiovascular disease Diabet. Med. 14 3 Suppl. 1997 S25 S31
42. L. Quangwei, P. Zhang, and J. Wang The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study Lancet 371 2008 1783 1789